Fig 1.
Flow chart of study population selection.
AlloHSCT = allogeneic hematopoietic stem cell transplantation; AuHSCT = autologous hematopoietic stem cell transplantation; MM = multiple myeloma.
Table 1.
Baseline patient characteristics.
Fig 2.
Overall survival (A) and event-free survival (B) of the 1LOT groups.
In the analysis of event-free survival, the number of surviving patients at four years were less than three in some of the treatment groups; therefore, the data are not shown to protect the anonymity of the patients.
Table 2.
Comparison of overall survival and event-free survival among the 1LOT groups.
Table 3.
Crude and adjusted rate ratios of health care resource utilization among different 1LOT groups.
Fig 3.
Average cost (per patient per month) within one year after commencement of the 1LOT.
The asterisk (*) represents that the cost ratio (compared with the V+T-based group) achieved a significant difference. The bar with white slanted lines represents the IPD non-drug-related costs, and the bar with white dots represents the IPD drug-related costs. ER = emergency room; IPD = hospitalizations; OPD = outpatient.